Drug Eluting Balloons Market Research Report Information By Product (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon And Others), By Technology (Paccocath, FreePac, TransPax, EnduraCoat, Others), By End-user (Hospitals and Ambulatory Surgery Centers, Cath Labs And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL DRUG ELUTING BALLOONS MARKET, BY PRODUCT

6.1. Overview

6.2. Coronary Drug Eluting Balloon

6.3. Peripheral Drug Eluting Balloon

6.4. Others

7. GLOBAL DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY

7.1. Overview

7.2. Paccocath

7.3. FreePac

7.4. TransPax

7.5. EnduraCoat

7.6. Others

8. GLOBAL DRUG ELUTING BALLOONS MARKET, BY END-USER

8.1. Overview

8.2. Hospitals and Ambulatory Surgery Centers

8.3. Cath Labs

8.4. Others

9. GLOBAL DRUG ELUTING BALLOONS MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Drug Eluting Balloons Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Drug Eluting Balloons Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Bayer AG

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Medtronic

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. B. Braun Melsungen AG

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Cook Medical, Inc.

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. BOSTON SCIENTIFIC CORPORATION

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Becton, Dickson and Company

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. EuroCor

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. TERUMO CORPORATION

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Koninklijke Philips N.V.

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL DRUG ELUTING BALLOONS MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL DRUG ELUTING BALLOONS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 9 US: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 10 US: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 11 US: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 12 CANADA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 13 CANADA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 14 CANADA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 10 ITALY: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 11 ITALY: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 12 ITALY: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 16 UK: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 17 UK: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 18 UK: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 28 CHINA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 29 CHINA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 30 CHINA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 31 INDIA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 32 INDIA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 33 INDIA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DRUG ELUTING BALLOONS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DRUG ELUTING BALLOONS MARKET

FIGURE 4 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY PRODUCT, 2023

FIGURE 5 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY TECHNOLOGY, 2023

FIGURE 6 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY END-USER, 2023

FIGURE 7 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL DRUG ELUTING BALLOONS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 BAYER AG: SWOT ANALYSIS

FIGURE 15 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 MEDTRONIC: SWOT ANALYSIS

FIGURE 17 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS

FIGURE 19 COOK MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 COOK MEDICAL, INC.: SWOT ANALYSIS

FIGURE 21 BOSTON SCIENTIFIC CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 BOSTON SCIENTIFIC CORPORATION.: SWOT ANALYSIS

FIGURE 23 BECTON, DICKSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 BECTON, DICKSON AND COMPANY: SWOT ANALYSIS

FIGURE 25 EUROCOR: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 EUROCOR: SWOT ANALYSIS

FIGURE 27 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 TERUMO CORPORATION: SWOT ANALYSIS

FIGURE 29 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS